Long Focus Capital Management, LLC Marker Therapeutics, Inc. Transaction History

Long Focus Capital Management, LLC

  • $2.73 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.3 - $3.73 $292,458 - $3.64 Million
-974,863 Reduced 40.02%
1,461,000 $539,000
Q1 2022

May 13, 2022
BUY
$0.37 - $1.0 $444,964 - $1.2 Million
1,202,606 Added 97.51%
2,435,863 $1.07 Million
Q4 2021

Feb 14, 2022
BUY
$0.95 - $1.72 $1.17 Million - $2.12 Million
1,233,257 New
1,233,257 $1.17 Million

Others Institutions Holding MRKR

# of Institutions
5
Shares Held
475K
Call Options Held
0
Put Options Held
0
View Full List

About Marker Therapeutics, Inc.

MRKR Quotes by TradingView
  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $269M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Long Focus Capital Management, LLC Portfolio

Follow Long Focus Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Focus Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Focus Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email